Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK1 | P49759 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.38 |
| ▸ | HASPIN | Q8TF76 | 10/20 | 0.37 |
| ▸ | AHR | P35869 | 3/20 | 0.36 |
| ▸ | PIM1 | P11309 | 3/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.36 |
| ▸ | CDK9 | P50750 | 3/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23944611 | 1.00 | CLK1 (0.41) | CLK1TTRHASPINAHRPIM1 | |
| SCHEMBL21115357 | 0.82 | AHR (0.47) | TTRAHR | |
| SCHEMBL24911363 | 0.81 | AHR (0.44) | CLK1TTRHASPINAHRPIM1 | |
| SCHEMBL24911816 | 0.81 | AHR (0.44) | CLK1TTRHASPINAHRPIM1 | |
| SCHEMBL26423191 | 0.78 | CLK1 (0.49) | CLK1HASPINAHRPIM1CCNT1 | |
| SCHEMBL17756864 | 0.78 | CLK1 (0.49) | CLK1HASPINAHRPIM1CCNT1 | |
| SCHEMBL24055800 | 0.78 | TTR (0.40) | TTRAHRROCK2IDO1TDO2 | |
| SCHEMBL24056383 | 0.78 | TDO2 (0.46) | TTRAHRROCK2IDO1TDO2 | |
| SCHEMBL23944683 | 0.76 | HASPIN (0.43) | CLK1HASPINAHRPIM1CCNT1 | |
| SCHEMBL24910922 | 0.76 | AHR (0.53) | CLK1TTRHASPINAHRPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023287255-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| US-20220402928-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| WO-2021210910-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402928-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, CRY1, CRY2 | CLK1 458/4885TTR 3884/4885HASPIN 4710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.